Difficult reputations and the social reality of occupational medicine

New Solutions

Volumn 18, Issue 3, 2008, Pages 299-316

  Draper, Elaine ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFLICT; ETHICS; HUMAN; MASS SCREENING; NOTE; OCCUPATIONAL MEDICINE; PHYSICIAN ATTITUDE; PUBLIC RELATIONS; SOCIAL PSYCHOLOGY;

CONFLICT (PSYCHOLOGY); HUMANS; MASS SCREENING; OCCUPATIONAL MEDICINE; PHYSICIAN'S ROLE; PREJUDICE; PUBLIC RELATIONS;

EID: 60249088225     PISSN: 10482911     EISSN: 15413772     Source Type: Journal    
DOI: 10.2190/NS.18.3.c     Document Type: Article

References (30)

1. T. Guidotti, Occupational Medicine and the Construction of “Difficult Reputations,” New Solutions, 18:3, pp. 285-298, September 2008.
2. E. Draper, The Company Doctor: Risk, Responsibility, and Corporate Professionalism, Russell Sage Foundation, New York, 2003.
3. E. Draper, Risky Business: Genetic Testing and Exclusionary Practices in the Hazardous Workplace. Cambridge University Press, New York, 1991.
4. Other reviewers also commend the description of occupational physicians in The Company Doctor as harbingers in medicine or emblematic for professionals generally, with the growing influence of corporations on professional practice (see, e.g., Journal of Legal Medicine, 26(1), pp. 141-154
5. March 2005: “Draper has done us a great service by initiating a much-needed examination of issues that are important to many physicians working in and for corporations”; Industrial and Labor Relations Review, 57(3), pp. 470-472
6. April 2004: “should be read by anyone—professional or other-wise—employed by a large complex organization”; and Administrative Science Quarterly, 48(2), pp. 311-314
7. June 2003: “superb research”. An occupational physician with many years’ experience practicing in a major corporation and in government reviewed The Company Doctor in ACOEM’s own journal, the Journal of Occupational and Environmental Medicine, 47(5), pp. 535-536
8. May 2005. Richard Lippin highly recommends the book as “excellent” and “thoroughly researched.” Many other reviews of the book highlight the chapters on how company doctors deal with the law, toxics, drug testing, and medical information, commending the book as a sensitive and sympathetic portrayal of occupational physicians confronting problems common among corporate and medical professionals.
9. R. Jackall, Moral Mazes: The World of Corporate Managers, Oxford University Press, New York, 1988.
10. G. Kunda, Engineering Culture: Control and Commitment in a High-Tech Corporation, Temple University Press, Philadelphia, 1992.
11. D. A. Moore, D. M. Cain, G. Loewenstein, and M. H. Bazerman (eds.), Conflicts of Interest: Challenges and Solutions in Business, Law, Medicine, and Public Policy, Cambridge University Press, New York, 2005.
12. J. Robinson, The Corporate Practice of Medicine: Competition and Innovation in Health Care, University of California Press, Berkeley, 1999.
13. R. L. Nelson and L. B. Nielson, Cops, Counsel, and Entrepreneurs: Constructing the Role of Inside Counsel in Large Corporations, Law and Society Review, 34(2), pp. 457-493, 2000.
14. T. Frankl, Trust and Honesty: America’s Business Culture at a Crossroad, Oxford University Press, New York, 2006.
15. J. Rothschild and T. D. Miethe, Whistleblower Disclosures and Management Retaliation: The Battle to Control Information about Organizational Corruption, Work and Occupations, 1(1), pp. 107-128, 1999.
16. M. Millman, Medical Mortality Review: A Cordial Affair, in The Sociology of Health and Illness: Critical Perspectives, P. Conrad and R. Kern (eds.), St. Martin’s Press, New York, pp. 97-119, 1981.
17. G. A. Fine, Difficult Reputations: Collective Memories of the Evil, Inept, and Controversial, University of Chicago Press, Chicago, 2001.
18. W. Wagner and R. Steinzor (eds.), Rescuing Science from Politics: Regulation and the Distortion of Scientific Research, Cambridge University Press, New York, 2006.
19. S. Krimsky, Science in the Private Interest: Has the Lure of Profits Corrupted Biomedical Research? Rowman and Littlefield, Lanham, Maryland, 2003.
20. S. Kamieniecki, Corporate America and Environmental Policy: How Often Does Business Get Its Way? Stanford University Press, Stanford, California, 2006.
21. D. Blumenthal, Growing Pains for New Academic/Industry Relationships, Health Affairs, 13, pp. 176-193, Summer 1994.
22. M. Angell, The Truth About the Drug Companies: How They Deceive Us and What To Do About It, Random House, New York, 2004.
23. J. LaDou, D. T. Teitelbaum, D. S. Egilman, A. L. Frank, S. N. Kramer, and J. Huff, American College of Occupational and Environmental Medicine (ACOEM): A Professional Association in Service to Industry, International Journal of Occupational and Environmental Health, 13(4), pp. 404-426, 2007.
24. C. Cranor, Toxic Torts: Science, Law, and the Possibility of Justice, Cambridge University Press, New York, 2006.
25. T. Duster, Backdoor to Eugenics (2nd edition), Routledge, New York, 2003.
26. R. J. Lifton, The Nazi Doctors: Medical Killing and the Psychology of Genocide, Basic Books, New York, 1986.
27. S. E. Lederer, Subjected to Science: Human Experimentation in America Before the Second World War, Johns Hopkins University Press, Baltimore, Maryland, 1995.
28. J. Jones, Bad Blood: The Tuskegee Syphilis Experiment, Free Press, New York, 1981.
29. D. J. Kevles, In the Name of Eugenics: Genetics and the Uses of Human Heredity, Alfred A. Knopf, New York, 1985.
30. Corporate Criminal Liability Act, California Penal Code, Section 387 (West, 2008).